You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

CLINICAL TRIALS PROFILE FOR SODIUM LACTATE IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Sodium Lactate In Plastic Container

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Diabetes Australia N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Hoffmann-La Roche N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed National Health and Medical Research Council, Australia N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Baker Heart Research Institute N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00279617 ↗ Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks Completed UCB Pharma Phase 3 2006-01-01 The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Lactate In Plastic Container

Condition Name

Condition Name for Sodium Lactate In Plastic Container
Intervention Trials
Septic Shock 3
Hyperlactatemia 3
Lactate 3
Intracranial Hypertension 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Lactate In Plastic Container
Intervention Trials
Shock 8
Wounds and Injuries 5
Brain Injuries 5
Shock, Septic 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Lactate In Plastic Container

Trials by Country

Trials by Country for Sodium Lactate In Plastic Container
Location Trials
United States 14
France 6
Indonesia 5
Ukraine 4
Moldova, Republic of 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Lactate In Plastic Container
Location Trials
California 3
Utah 1
Pennsylvania 1
New Mexico 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Lactate In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Sodium Lactate In Plastic Container
Clinical Trial Phase Trials
Phase 4 23
Phase 3 15
Phase 2/Phase 3 4
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Lactate In Plastic Container
Clinical Trial Phase Trials
Completed 34
Not yet recruiting 14
Recruiting 11
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Lactate In Plastic Container

Sponsor Name

Sponsor Name for Sodium Lactate In Plastic Container
Sponsor Trials
Innogene Kalbiotech Pte. Ltd 5
Yuria-Pharm 4
The First Affiliated Hospital with Nanjing Medical University 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Lactate In Plastic Container
Sponsor Trials
Other 85
Industry 20
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sodium Lactate: Clinical Trials, Market Analysis, and Projections

Clinical Trials Overview

Sodium lactate, a natural compound derived from the fermentation of sugars, is being explored in various clinical trials for its therapeutic potential.

Antidepressant Effects

A notable clinical trial is assessing the efficacy of sodium lactate as an adjunctive therapy in patients hospitalized for major depressive episodes. This single-center study involves administering sodium lactate intravenously daily for 5 days, in addition to standard antidepressant treatment. The trial aims to evaluate the feasibility of conducting a larger-scale study and assess the therapeutic effect using the MADRS score at multiple time points. The study also monitors other parameters such as anxiety, perceived stress, insomnia, and short-term depression remission rate[1].

Post-Cardiac Arrest Treatment

Another clinical trial is investigating the use of hypertonic sodium lactate (HSL) in patients resuscitated after cardiac arrest. This phase II trial tests the hypothesis that HSL infusion can reduce the magnitude of brain damage and organ injury in these patients. Participants are randomized to receive either HSL infusion or standard care, and the trial evaluates the safety and efficacy of HSL in reducing biomarkers of organ damage[4].

Market Analysis

Market Size and Growth

The global sodium lactate market is experiencing significant growth, driven by its versatile applications across various industries. As of 2023, the market was valued at approximately USD 290.78 million and is projected to reach USD 591.03 million by 2032, growing at a CAGR of 8.2% during the forecast period[5].

Market Segmentation

The sodium lactate market is segmented by form, packaging type, and end-use industry.

By Form

Liquid sodium lactate holds a substantial market share, around 73.7% as of 2023, due to its ease of handling and adaptability across industries such as food, pharmaceuticals, and personal care. Powdered sodium lactate, though less dominant, still has its niche applications[2].

By Packaging Type

Both glass and plastic bottles are used for packaging sodium lactate, each offering unique advantages. Glass bottles are prized for their durability and environmental friendliness, while plastic bottles are preferred for their lightweight and convenience[2].

By End-Use Industry

  • Cosmetics and Personal Care: This sector holds a significant market share, around 33.6%, driven by the rising consumer preference for natural and organic additives.
  • Food and Beverage: Sodium lactate is used as a preservative, bulking agent, and acidity regulator, contributing to its growth in this sector.
  • Pharmaceuticals: The use of sodium lactate in pharmaceutical formulations, particularly in intravenous fluids, CAPD (Continuous Ambulatory Peritoneal Dialysis), and as a buffering agent, is a major driver for market growth[2][3].

Regional Analysis

The Asia-Pacific region, particularly countries like China and India, offers substantial growth potential for the sodium lactate market. Rapid urbanization, expanding middle class, and increasing disposable incomes in these regions drive the demand for processed foods, pharmaceuticals, and personal care products where sodium lactate is a key ingredient[5].

Market Drivers and Opportunities

Drivers

  • Rising Consumer Preference for Natural Ingredients: The increasing demand for natural and organic additives in cosmetics, personal care items, and food products drives the growth of the sodium lactate market.
  • Multifunctional Properties: Sodium lactate's role as a preservative, humectant, and pH regulator makes it a versatile ingredient across various industries.
  • Growing Pharmaceutical Industry: The use of sodium lactate in pharmaceutical formulations, especially in intravenous solutions and as a buffering agent, contributes significantly to market growth[2][3].

Opportunities

  • Technological Developments: Research and development initiatives aimed at increasing the efficiency and exploring novel applications of sodium lactate could open new avenues for market expansion.
  • Expanding Applications in Pharmaceuticals: The potential use of sodium lactate in medical devices, therapies, and its increasing demand in intravenous therapies present significant opportunities for growth[2][3].

Challenges and Restraints

  • Availability of Alternative Ingredients: The presence of alternative pharmaceutical ingredients that can perform similar functions as sodium lactate might pose a challenge to its market growth.
  • Price Volatility of Raw Materials: Fluctuations in the prices of raw materials used in the production of sodium lactate can impact its market stability[3].

Key Takeaways

  • Clinical Trials: Sodium lactate is being explored for its therapeutic potential in treating major depressive disorder and reducing organ damage post-cardiac arrest.
  • Market Growth: The global sodium lactate market is projected to grow significantly, driven by its applications in cosmetics, food, and pharmaceutical industries.
  • Regional Focus: The Asia-Pacific region, particularly China and India, is expected to witness substantial growth due to increasing demand for natural and organic products.
  • Drivers and Opportunities: Rising consumer preference for natural ingredients, multifunctional properties, and growing pharmaceutical industry are key drivers. Technological developments and expanding pharmaceutical applications offer significant opportunities.

FAQs

What is the primary use of sodium lactate in clinical trials?

Sodium lactate is being tested as an adjunctive therapy for major depressive disorder and as a treatment to reduce organ damage in patients resuscitated after cardiac arrest.

What is the projected market size of the sodium lactate market by 2032?

The global sodium lactate market is estimated to reach approximately USD 591.03 million by 2032, growing at a CAGR of 8.2% during the forecast period.

Which regions are expected to drive the growth of the sodium lactate market?

The Asia-Pacific region, particularly countries like China and India, is expected to witness significant growth due to rapid urbanization and increasing demand for natural and organic products.

What are the key drivers of the sodium lactate market?

Key drivers include rising consumer preference for natural ingredients, multifunctional properties of sodium lactate, and the growing pharmaceutical industry.

What challenges might affect the growth of the sodium lactate market?

Challenges include the availability of alternative ingredients and price volatility of raw materials used in the production of sodium lactate.

Sources

  1. ClinicalTrials.gov: Feasibility of Conducting a Clinical Trial Assessing Efficacy of Lactate as Adjunctive Therapy in Patients Hospitalized for a Major Depressive Episode.
  2. Market.US: Sodium Lactate Market Size, Share | CAGR of 8%.
  3. Data Bridge Market Research: U.S. Sodium Lactate Market for Pharmaceutical Industries.
  4. ClinicalTrials.gov: Hypertonic Lactate After Cardiac Arrest.
  5. Straits Research: Sodium Lactate Market Size, Growth & Share | Forecast-2032.
Last updated: 2025-01-06

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.